MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 1.010
-0.020 (-1.94%)
Oct 2, 2026, 5:35 PM CET
MaaT Pharma Revenue
MaaT Pharma had revenue of 1.08M EUR in the half year ending June 30, 2026, a decrease of -37.30%. This brings the company's revenue in the last twelve months to 3.18M, down -19.02% year-over-year. In the year 2025, MaaT Pharma had annual revenue of 4.52M with 40.67% growth.
Revenue (ttm)
3.18M
Revenue Growth
-19.02%
P/S Ratio
5.99
Revenue / Employee
56.71K
Employees
59
Market Cap
19.03M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.52M | 1.31M | 40.67% |
| Dec 31, 2024 | 3.22M | 987.74K | 44.33% |
| Dec 31, 2023 | 2.23M | 798.26K | 55.82% |
| Dec 31, 2022 | 1.43M | 458.28K | 47.16% |
| Dec 31, 2021 | 971.73K | 310.09K | 46.87% |
| Dec 31, 2020 | 661.64K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 26.03M |
| Nicox | 16.77M |
| Fermentalg | 13.38M |
| Poxel | 7.66M |
| Advicenne | 6.50M |
| Aelis Farma | 2.19M |
| THX Pharma Société Anonyme | 806.05K |
| Aton | 661.00K |
MaaT Pharma News
- 3 days ago - MaaT Pharma Quarterly report: H1 2026 - Filings
- 3 days ago - MaaT Pharma Earnings release: H1 2026 - Filings
- 3 months ago - MaaT Pharma Slides: Corporate presentation - Filings
- 3 months ago - MaaT Pharma Slides: FY 2026 - Filings
- 4 months ago - MaaT Pharma Earnings release: Q1 2026 - Filings
- 6 months ago - MaaT Pharma Earnings release: H2 2025 - Filings
- 6 months ago - MaaT Pharma Slides: H2 2025 - Filings
- 6 months ago - MaaT Pharma Annual report: H2 2025 - Filings